Booz Allen Hamilton, Inc. Q2 2027 Earnings Call - BOOZ ALLEN HAMILTON HOLDING CORP

Explicit Guidance:

• FY2027 Revenue: Raised to $11.3B–$11.6B, implying 1–3% growth (vs. prior expectations of higher civil growth).
• FY2027 Adjusted EBITDA: Raised bottom end to $1.26B–$1.29B; implies a step-down in margins in H2 due to typical seasonality and investment timing.
• FY2027 Adjusted EPS: Raised range to $6.50–$6.70, incorporating CVC gains, DARPA divestiture earn-out ($10M), and a lower expected tax rate.
• FY2027 Free Cash Flow: Guided at $850M–$925M, reflecting strong collections, slightly lowered CapEx, and incremental costs/interest from Ultra acquisition.
• Quarterly Cadence (H2 FY2027): Civil revenue expected to be flat to slightly down sequentially in Q3 and Q4; National Security expected to accelerate with mid-single-digit growth for the full year.

Business-Segment Outlook:

• National Security: Expects strong growth acceleration in H2, driven by funded backlog up 10% YoY and pipeline up >20% YoY. "Ex-billable" revenue growth of 6% in Q2 sets a baseline for continued strength.
• Civil: Revenue expected to decline low double-digits for FY2027 (slightly softer than initial guidance). Headwinds from recompetes with smaller scope/duration are expected to ease, with flat-to-slightly-down sequential performance in H2.
• Ultra Mission Solutions Integration: Acquisition fully integrated into defense tech portfolio; contributes to growth with margins "well above 20%" and expected double-digit growth. Cultural integration viewed as seamless.
• Product Lines:
  • Velox (Cyber): Moving faster than planned into private beta; products like "GAIL" (counter-AI) showing 95% attack reduction in testing. Full product suite launch accelerated over two-year window.
  • Defense Tech: Accelerating growth via Ultra acquisition, enhancing C3BM (Command, Control, Battle Management) and autonomy portfolios.
• Contract Mix: Firm fixed-price (outcome-based) contracts increasing; mix grew 3 percentage points YTD. Shift expected to drive margin expansion over time.

Market and Competitive Outlook:

• Cyber Demand: Significant demand for AI-enabled cyber defense (agentic AI, zero trust, incident response) across government and commercial sectors due to autonomous threats.
• Civil Procurement Dynamics: Awards and re-competes shifting "to the right" (delayed timing) due to fiscal pressures, though pipeline remains strong in agentic software and AI-ready data platforms (e.g., healthcare, public safety).
• Market Share/Positioning: Company positioned to lead in "outcome-based" contracting; expects to decouple growth from headcount through productization and IP.

Macro / Industry Outlook:

• Federal Budget: Acknowledges choppy funding environment and continuing resolutions; guidance incorporates various budget scenarios. Strong funding activity observed in September to close the government fiscal year.
• Geopolitics: Ongoing conflicts and changing warfare nature driving demand for advanced capabilities at the tactical edge.
• Election Impact: Anticipates bipartisan support for outcome-based contracting reforms (NDAA) remains stable regardless of election outcomes; focuses on execution over political prediction.
• FX/Tax: Lower tax rate anticipated for remainder of year due to planning updates on recent tax law changes.

Strategic Initiatives:

• M&A: Acquired Ultra Mission Solutions (August) for $729M; integrating to expand defense tech and C3BM portfolios.
• Product Development: Accelerating "Velox" suite and "GAIL" product; investing heavily in Super Intelligence (SI), Agentic AI, physical AI, Quantum, and 6G.
• Capital Allocation: Total deployment of $965M in Q2 (including Ultra acquisition, $66M strategic venture investments, $170M shareholder returns). Maintains balanced strategy for deleveraging post-acquisition while continuing dividends and modest buybacks.
• Workforce: Hiring ramping in National Security (+300 employees in Q2); decoupling growth from headcount via technology and productization.

Risks and Headwinds to Outlook:

• Civil Sector Volatility: Continued delays in award timing ("pushing to the right") and smaller scope recompete impacts could slow recovery.
• Funding Uncertainty: Federal budget process volatility and potential continuing resolutions remain a variable for Q1/H1 execution.
• Margin Seasonality: Margins expected to step down in H2 due to seasonality and timing of investment spending.
• Adoption Speed: Early-stage product adoption (Velox/GAIL) may ramp more slowly than promised in the near term despite strong beta interest.

Management Tone on the Future:

• Confidence Level: High confidence in "accelerating medium-term growth" and "above-market top-line growth" (targeting mid-single digits) and margin expansion.
• Strategic Narrative: Shift from labor-driven growth to technology/product-driven growth; management emphasizes "unwavering commitment" and "exceptional execution."
• Guidance Changes: Upward revision to EPS and EBITDA ranges; downward adjustment to Civil decline; overall view is "on track" with strategic transformation.

Miscellaneous:

• Book-to-Bill: Q2 book-to-bill of 1.5x; trailing 12-month at 1.1x.
• Backlog: Total backlog ~$41B (+2% YoY); Funded backlog $5.7B (+5% YoY).
• Efficiency Metrics: Days Sales Outstanding (DSO) at 82 days (elevated due to DeFi acquisition); free cash flow generation robust at $263M in Q2.